CLINICAL_TRIALS
trial_result
· 2019-01-04
Clinical Trial Update: Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus [Phase 2]
Summary
Phase 2 safety and efficacy study of a biologic for systemic lupus erythematosus has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Lupus | Phase 2 | Status: COMPLETED | Results posted: 2019-01-04